Pyxis Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 34.2%.

Top 25 shareholders own 67.95% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10%	Pfizer Inc.	5,952,263	US$24.8m	0%	no data
7.31%	Ridgeback Capital Management LLC	4,345,228	US$18.1m	0%	21.93%
7.04%	Deep Track Capital, LP	4,184,100	US$17.4m	0%	0.54%
6.1%	Laurion Capital Management LP	3,625,974	US$15.1m	-6.09%	0.97%
4.68%	BlackRock, Inc.	2,785,895	US$11.6m	0%	no data
4.61%	Bayer Aktiengesellschaft	2,742,338	US$11.4m	0%	no data
4.09%	The Vanguard Group, Inc.	2,432,953	US$10.1m	18.1%	no data
3.21%	Millennium Management LLC	1,906,978	US$7.9m	42.6%	0.01%
3.14%	Lara Sullivan	1,866,547	US$7.8m	0%	no data
1.89%	CHI Advisors LLC	1,126,025	US$4.7m	7.65%	1.78%
1.82%	Geode Capital Management, LLC	1,084,727	US$4.5m	5.55%	no data
1.82%	Pfizer Venture Investments LLC	1,080,507	US$4.5m	0%	100.0%
1.61%	Ikarian Capital, LLC	957,408	US$4.0m	-42.4%	1.14%
1.6%	State Street Global Advisors, Inc.	951,251	US$4.0m	28%	no data
1.54%	abrdn plc	913,045	US$3.8m	28.9%	no data
1.43%	StemPoint Capital LP	850,210	US$3.5m	-29.3%	1.12%
0.89%	Pamela Connealy	529,050	US$2.2m	0%	no data
0.86%	Perceptive Advisors LLC	508,462	US$2.1m	0%	0.05%
0.7%	683 Capital Management, LLC	414,656	US$1.7m	0%	0.17%
0.66%	Northern Trust Global Investments	394,035	US$1.6m	207%	no data
0.64%	Jacobs Levy Equity Management Inc	382,840	US$1.6m	0%	0.01%
0.64%	Hillhouse Investment Management, Ltd.	382,606	US$1.6m	0%	0.01%
0.64%	John Flavin	377,796	US$1.6m	0%	no data
0.55%	Decheng Capital LLC	326,810	US$1.4m	0%	0.29%
0.48%	Boothbay Fund Management, LLC	283,616	US$1.2m	-42.4%	0.04%